GC
SWAV

Guggenheim Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Guggenheim Capital’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,899
Closed -$1.27M – 1963
2024
Q1 		$1.27M Buy
+3,899
New +$957K 0.01% 1082
2023
Q4 		– Sell
-6,194
Closed -$1.23M – 1975
2023
Q3 		$1.23M Buy
6,194
+597
+11% +$141K 0.01% 1008
2023
Q2 		$1.6M Sell
5,597
-757
-12% -$210K 0.01% 952
2023
Q1 		$1.38M Sell
6,354
-2,051
-24% -$400K 0.01% 1017
2022
Q4 		$1.73M Sell
8,405
-5,288
-39% -$1.34M 0.02% 908
2022
Q3 		$3.81M Buy
13,693
+1,480
+12% +$376K 0.03% 599
2022
Q2 		$2.33M Buy
+12,213
New +$2.16M 0.02% 829

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Guggenheim Capital's SWAV Position: Q2 2024 in Review

Guggenheim Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 3,899 shares — an estimated $1.27M sold.

Guggenheim Capital first reported a position in SWAV in Q2 2022 and held it in 7 quarters. The position peaked at $3.81M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Guggenheim Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Guggenheim Capital sold 3,899 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.27M.
  • Guggenheim Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Guggenheim Capital's Shockwave Medical, Inc. Common Stock position peaked at $3.81M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Guggenheim Capital's 13F filing for Q2 2024, filed 14 Aug 2024.